Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Supplementation vs GFD in Pediatric Celiac Disease
NCT06921343Not yet recruiting
- Sponsor
- Kaplan Medical Center
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Kaplan Medical Center. Primary endpoint: Change in ferritin levels at 12 months. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06921343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06921343.